MENU
AKBA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Akebia Therapeutics (AKBA) Earnings Date & Reports
Akebia Therapeutics Inc is a fully integrated biopharmaceutical company... Show more
Industry: #Biotechnology
A.I. Advisor
published Earnings
AKBA is expected to report earnings to rise 53.33% to -4 cents per share on October 29
Q3'26
Est.
$-0.05
Q2'26
Beat
by $0.01
Q1'26
Missed
by $0.02
Q4'25
Missed
by $0.05
Q3'25
Beat
by $0.04
The last earnings report on August 05 showed earnings per share of -2 cents, beating the estimate of -3 cents. With 5.25M shares outstanding, the current market capitalization sits at 251.22M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information
General Information
a developer of drugs for the treatment of anemia and vascular diseases
Industry PharmaceuticalsGeneric
Profile
Details
Industry
Biotechnology
Address
245 First Street
Phone
+1 617 871-2098
Employees
194
Web
https://www.akebia.com